Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03297606
Title Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications

Advanced Solid Tumor

non-Hodgkin lymphoma

multiple myeloma

Therapies

Bosutinib

Palbociclib

Vismodegib

Ipilimumab + Nivolumab

Cobimetinib + Vemurafenib

Temsirolimus

Olaparib

Erlotinib

Crizotinib

Sunitinib

Afatinib

Dasatinib

Pertuzumab + Trastuzumab

Axitinib

Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST